Immunohistochemical Expression of Cyclin D1 in Oral Squamous Cell Carcinoma: Relationship With Clinicodemographic and Histopathological Features
NCT07778615 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2026-08-21
Summary
Oral squamous cell carcinoma is a major public health problem , especially in West Asian countries. Cyclin D1 accelerates cell cycle and thus may be implicated in uncontrolled cellular proliferation and tumor progression.
Conditions
- Oral Squamous Cell Carcinoma (OSCC)
Interventions
- BIOLOGICAL
-
immunohistochemical expression of Cyclin D1 on oral squamous cell carcinoma tissue sections
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2025-12-31
- Completion
- 2026-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.
NCT01919567 ·Status: UNKNOWN
-
Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population
NCT06471270 ·Status: COMPLETED ·Phase: NA
-
Salivary LINC00657 as a Diagnostic Biomarker for Oral Squamous Cell Carcinoma
NCT05821179 ·Status: COMPLETED
-
Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line
NCT05456022 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Anti-cancerous Effect of Green, Roasted and Decaffeinated Coffee on Oral Squamous Cell Carcinoma Cell Line
NCT03619304 ·Status: UNKNOWN ·Phase: NA
-
Dipeptidyl Peptidase-4 Link With Oral Cancer and Premalignant Lesions
NCT06087042 ·Status: COMPLETED
-
Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
NCT00154973 ·Status: UNKNOWN
-
The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma
NCT01946230 ·Status: UNKNOWN
-
Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions
NCT02323672 ·Status: COMPLETED
-
Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients
NCT04387682 ·Status: UNKNOWN ·Phase: NA
-
The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw
NCT03418454 ·Status: UNKNOWN
-
Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma
NCT00201279 ·Status: COMPLETED ·Phase: PHASE3
-
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma
NCT06606301 ·Status: COMPLETED
-
Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions
NCT04955197 ·Status: UNKNOWN
-
Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression
NCT01531881 ·Status: COMPLETED
-
Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
NCT01636544 ·Status: COMPLETED ·Phase: NA
-
Developing an In-vitro Diagnostic Risk-Stratification Test for Oral Cancer
NCT01587573 ·Status: UNKNOWN
-
Association of Salivary Amino Acid Level With OSCC Identified By Liquid Chromatography Mass Spectroscopy
NCT05150509 ·Status: UNKNOWN
-
WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA
NCT05927220 ·Status: UNKNOWN
-
Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
NCT01987934 ·Status: UNKNOWN
-
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
NCT04732741 ·Status: UNKNOWN
-
Clinical and Immunohisochemical Evaluation of Chemopreventive Effect of Thymoquinone on Oral Potentially Malignant Lesions.
NCT03208790 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Microbioma and Oral Malignant Disease
NCT05766150 ·Status: UNKNOWN
-
Oral Cancer Screening in Workplace: a Cross-sectional Study
NCT06057857 ·Status: COMPLETED
-
A Study of High-Risk Oral Cavity Cancer
NCT00934739 ·Status: TERMINATED ·Phase: PHASE2/PHASE3